| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00004850-200015060-00002 |
| P698 | PubMed publication ID | 11110007 |
| P50 | author | Hans-Ulrich Wittchen | Q1435357 |
| Ronald C. Kessler | Q7364712 | ||
| P2093 | author name string | S A Montgomery | |
| H Pfister | |||
| R M Carter | |||
| P433 | issue | 6 | |
| P921 | main subject | quality of life | Q13100823 |
| generalized anxiety disorder | Q845224 | ||
| P304 | page(s) | 319-328 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | International Clinical Psychopharmacology | Q15751307 |
| P1476 | title | Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey | |
| P478 | volume | 15 |
| Q36797810 | A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal |
| Q36366194 | A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder |
| Q34988165 | A preliminary investigation of worry content in sexual minorities |
| Q79243035 | A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety |
| Q35889453 | AN OPEN TRIAL OF EMOTION REGULATION THERAPY FOR GENERALIZED ANXIETY DISORDER AND COOCCURRING DEPRESSION |
| Q39714031 | Anxiety and depression, chronic physical conditions, and quality of life in an urban population sample study |
| Q35561526 | Anxiety disorders in women |
| Q33551974 | Anxiety, Gambling Activity, and Neurocognition: A Dimensional Approach to a Non-Treatment-Seeking Sample. |
| Q34024116 | Beyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder |
| Q21260318 | Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study |
| Q36577463 | Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample. |
| Q36694888 | Characterization of Disability in Canadians with Mental Disorders Using an Abbreviated Version of a DSM-5 Emerging Measure: The 12-Item WHO Disability Assessment Schedule (WHODAS) 2.0. |
| Q41436259 | Childhood Trauma Associated with Enhanced High Frequency Band Powers and Induced Subjective Inattention of Adults |
| Q34948202 | Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder |
| Q35377785 | Combined medication and cognitive therapy for generalized anxiety disorder |
| Q48038195 | Complex coevolution of depression and health-related quality of life in old age. |
| Q37837718 | Contextual conditioning in rats as an animal model for generalized anxiety disorder |
| Q38905913 | Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe |
| Q37378694 | Current considerations in the treatment of generalized anxiety disorder |
| Q34532410 | Current evolutionary adaptiveness of psychiatric disorders: Fertility rates, parent-child relationship quality, and psychiatric disorders across the lifespan |
| Q36776669 | Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample |
| Q48287081 | Distinct electrocortical and behavioral evidence for increased attention to threat in generalized anxiety disorder |
| Q83593183 | Duloxetine in the treatment of generalized anxiety disorder |
| Q34491459 | ECNP Consensus Meeting March 2000. Guidelines for investigating efficacy in GAD. |
| Q36115005 | Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder |
| Q37822308 | Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials |
| Q50224610 | Efficacy of vortioxetine in working patients with generalized anxiety disorder |
| Q55384029 | Emotion Regulation in Current and Remitted Depression: A Systematic Review and Meta-Analysis. |
| Q47718437 | Examining the Psychometric Properties of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in Two Samples of Youth with OCD. |
| Q79930637 | Factors influencing health-related quality of life of Asians with anxiety disorders in Singapore |
| Q51922138 | Feasibility of mental health screening and intervention in the HUNT population study. |
| Q45155184 | Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder |
| Q38817470 | Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms |
| Q36612447 | Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). |
| Q51835142 | Generalised anxiety disorder in Singapore: prevalence, co-morbidity and risk factors in a multi-ethnic population. |
| Q35817586 | Generalized anxiety disorder in primary care: mental health services use and treatment adequacy |
| Q42256746 | Generalized anxiety disorder within the course of major depressive disorder: examining the utility of the DSM-IV hierarchy rule |
| Q51951517 | Generalized anxiety disorder: prevalence, burden, and cost to society. |
| Q37670715 | Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V. |
| Q51877005 | Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder. |
| Q34094392 | Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study |
| Q36674056 | Human and economic burden of generalized anxiety disorder |
| Q79338373 | Impairment and quality of life in individuals with generalized anxiety disorder |
| Q36859855 | Increased error-related brain activity distinguishes generalized anxiety disorder with and without comorbid major depressive disorder |
| Q37432545 | Is generalized anxiety disorder an anxiety or mood disorder? Considering multiple factors as we ponder the fate of GAD |
| Q53254258 | Lifetime symptoms of depression in Alzheimer's disease. |
| Q33946044 | Long-term positive and negative psychological late effects for parents of childhood cancer survivors: a systematic review |
| Q38400543 | Longitudinal analysis of the relationship between PTSD symptom clusters, cigarette use, and physical health-related quality of life |
| Q35236313 | Mental disorders in primary care |
| Q60737263 | Mindfulness-based Cognitive Therapy for Generalized Anxiety Disorder: A Preliminary Evaluation |
| Q46153997 | Occupational functioning, sickness absence and medication utilization before and after cognitive-behaviour therapy for generalized anxiety disorders |
| Q55460810 | Physical activity and sedentary time are related to clinically relevant health outcomes among adults with obstructive lung disease. |
| Q42919182 | Point prevalence of major depression in Estonia. Results from the 2006 Estonian Health Survey |
| Q24604809 | Pregabalin for the treatment of generalized anxiety disorder: an update |
| Q45908575 | Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder. |
| Q92336345 | Prevalence and Correlates of Disability Among a Sample of Victimized Women on Probation and Parole |
| Q51935602 | Prevalence of psychiatric disorder in Europe: the potential and reality of meta-analysis. |
| Q47561962 | Psychiatrists' treatment preferences for generalized anxiety disorder. |
| Q89848854 | Religious Social Support, Discrimination, and Psychiatric Disorders among Black Adolescents |
| Q47179443 | Risk Factors, Clinical Presentations, and Functional Impairments for Generalized Anxiety Disorder in Military Personnel and the General Population in Canada |
| Q38209188 | Role of atypical antipsychotics in the treatment of generalized anxiety disorder |
| Q43699530 | Suicide attempts versus nonsuicidal self-injury among individuals with anxiety disorders in a nationally representative sample |
| Q36208542 | Testing the Short and Screener versions of the Social Adjustment Scale-Self-report (SAS-SR) |
| Q49348734 | The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients |
| Q51935711 | The association between physical exercises and health-related quality of life in subjects with mental disorders: results from a cross-sectional survey. |
| Q36127270 | The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization |
| Q24814389 | The distribution of the common mental disorders: social inequalities in Europe |
| Q34536698 | The impact of GPX1 on the association of groundwater selenium and depression: a Project FRONTIER study |
| Q38291371 | The impact of medication on health-related quality of life in patients with generalized anxiety disorder |
| Q30251737 | The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice |
| Q34608546 | The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study |
| Q89754254 | Transdiagnostic approaches to mental health problems: Current status and future directions |
| Q35565893 | Transdiagnostic dimensions of anxiety and depression moderate motivation-related brain networks during goal maintenance |
| Q37633180 | Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults |
| Q48342650 | Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials |
| Q39999736 | Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder |
| Q63090410 | WCA Recommendations for the Long-Term Treatment of Generalized Anxiety Disorder |
| Q46459376 | Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample |
| Q80981946 | [Patterns of clinical course in persons with mental disorders: which impact on social disability and quality of life? A longitudinal study] |
Search more.